Core Insights - The company, Boji Pharmaceutical, has collaborated with over 900 clinical trial service organizations as of the 2024 fiscal year, indicating a strong network in the clinical research sector [2] - Most top-tier hospitals have engaged in partnerships with the company, showcasing its extensive reach and credibility within the healthcare industry [2] Company Summary - Boji Pharmaceutical has established partnerships with more than 900 clinical trial service organizations [2] - The company has collaborated with a majority of top-tier hospitals, enhancing its operational capabilities and market presence [2]

Core Viewpoint - Tiger Medical (300347) announced that its wholly-owned subsidiary, Tiger Medical Japan, has signed a share transfer agreement with the original shareholders of MICRON to acquire a portion of MICRON's shares, resulting in Tiger Medical Japan holding 56.37% of MICRON's shares after the transfer [1] Company Summary - MICRON was established in 2005 and is headquartered in Tokyo, Japan, with over 160 employees. It specializes in medical imaging and clinical trial services as a CRO (Contract Research Organization) [1] - As of May 31, 2025, MICRON's total assets are 781 million JPY, while its net assets are -452 million JPY. For the period from January to May 2025, MICRON reported a revenue of 940 million JPY and a net loss of 67.04 million JPY [1]